Spring grazing managements which allowed some early inflorescence development, followed by hard grazing in order to remove the reproductive stems (designated ‘late control’), were compared with a conventional close grazing strategy (‘early control’) in three paddock-scale complete randomized block studies with dairy cows grazing perennial ryegrass/white clover pastures during consecutive years (1990–1993) in Palmerston North, New Zealand. Experiment 1 was designed to evaluate the timing of late control, Expt 2 to investigate the most suitable intensity of control, and Expt 3 tested different practical approaches to carrying out the late control management.Late control generated an average herbage production increase of 24% (750 kg DM/ha) in October and November (spring) and 22% (950 kg DM/ha) from January to April (summer–autumn) compared with the conventional management. The increase in herbage accumulation during spring was a consequence of greater perennial ryegrass reproductive development. Increased summer–autumn herbage accumulation after late control management was attributed to enhanced tillering activity and accumulation of perennial ryegrass. Effects on white clover production were inconsistent. Experiment 3 compared the effects of two practical late control strategies, involving either a short period of rapid rotational grazing or a simulation of increased stocking rate normally associated with forage conservation, on the milk production and forage intake of groups of cows in self-contained farmlet systems. During the control period, the reproductive state of the sward caused a small decrease in herbage digestibility. However, the extra herbage produced subsequently did not differ in digestibility from that produced on the conventionally managed sward and resulted in an increase of around 11·5% in total milk solids yield (fat, protein and lactose) per cow, particularly towards the end of the season (March and April).The late control spring grazing management strategy is a viable option for dairy farmers. It should coincide with the time of anthesis of ryegrass plants (late November–early December), and is more effectively achieved when forage conservation practices are used to augment grazing pressure in the grazed area of the farm.
Discrepancies in phase two and three studies can result in significant patient and financial burden, as well as the nonapproval of potentially efficacious drugs. We aimed to determine whether this discrepancy exists for clinical trials in inflammatory bowel disease (IBD). Electronic databases (MEDLINE and Embase) and clinical trial repositories were searched from 1 January 1946 to 12 March 2021, for paired phase two and three studies of advanced therapies for Crohn’s disease and ulcerative colitis. The primary outcome was to compare clinical remission rates between paired phase two and three studies for Crohn’s disease and ulcerative colitis. Multivariable mixed-model meta-analysis was performed to calculate odds ratios (OR) with 95% confidence intervals (CI). The Cochrane risk-of-bias tool was used to grade the risk of bias. Of 2642 studies, 29 were included. Fifteen were phase three, 11 were phase two, one was phase one/two, and two were phase two/three. There were no differences in clinical remission rates between phase two and three studies for Crohn’s disease (OR, 1.07; 95% CI, 0.86–1.34; P = 0.54) and ulcerative colitis (OR, 0.81; 95% CI, 0.48–1.36; P = 0.43). Furthermore, there was a lack of any appreciable differences in study characteristics, inclusion criteria and patient demographics among paired phase two and three studies. Most studies were considered low risk of bias. Overall, paired phase two and three studies demonstrate similar clinical remission rates for advanced therapies in IBD. Whether this applies to newer outcomes, such as endoscopic and mucosal healing remains to be determined.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.